CVM GFI #229 Evaluating the Effectiveness of New Animal Drugs for the Reduction of Pathogenic Shiga Toxin-Producing E coli in Cattle
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 19, 2015
April 16, 2019
cafa51a7-9df8-4840-9877-123cd25c033d
Related Documents
CVM GFI #231 Distributor Labeling for New Animal Drugs
Guidance DocumentApril 20, 2016Center for Veterinary Medicine
CVM GFI #218 Cell-Based Products for Animal Use
Guidance DocumentJune 12, 2015Center for Veterinary Medicine
CVM GFI #211 Residual Solvents in Animal Drug Products Questions and Answers
Guidance DocumentApril 3, 2015Center for Veterinary Medicine
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox